Anonymous (2026). The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).. Journal of the American College of Cardiology.
Anonymous. The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).. Journal of the American College of Cardiology. 2026; PMID: 42201287
Anonymous. The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).[J]. Journal of the American College of Cardiology. 2026.
@article{paper2026,
author = {Anonymous},
title = {The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).},
journal = {Journal of the American College of Cardiology},
year = {2026},
note = {PMID: 42201287},
}
TY - JOUR AU - Anonymous TI - The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC). T2 - Journal of the American College of Cardiology PY - 2026 AN - PMID:42201287 ER -
Interleukin (IL)-6 has emerged as a promising target for cardiovascular disease (CVD) prevention. Better understanding IL-6's contribution to CVD events in community-based, diverse cohorts and in clinically relevant subgroups will provide critical context about IL-6 inhibition for CVD prevention.